IDEAS home Printed from https://ideas.repec.org/a/spr/pharme/v30y2012i11p1085-1095.html
   My bibliography  Save this article

The General Public’s Willingness to Pay for Tax Increases to Support Unrestricted Access to an Alzheimer’s Disease Medication

Author

Listed:
  • Mark Oremus
  • Jean-Eric Tarride
  • Parminder Raina
  • Lehana Thabane
  • Gary Foster
  • Charlie Goldsmith
  • Natasha Clayton

Abstract

Background: Alzheimer’s disease (AD) is a neurodegenerative disorder highlighted by progressive declines in cognitive and functional abilities. Objective: Our objective was to assess the general public’s maximum willingness to pay M WTP for an increase in annual personal income taxes to fund unrestricted access to AD medications. Methods: We randomly recruited 500 Canadians nationally and used computer-assisted telephone interviewing to administer a questionnaire. The questionnaire contained four ‘efficacy’ scenarios describing an AD medication as capable of symptomatically treating cognitive decline or modifying disease progression. The scenarios also described the medication as having no adverse effects or a 30% chance of adverse effects. We randomized participants to order of scenarios and willingness-to-pay bid values; M WTP for each scenario was the highest accepted bid for that scenario. We conducted linear regression and bootstrap sensitivity analyses to investigate potential determinants of M WTP. Results: Mean M WTP was highest for the ‘disease modification/no adverse effects’ scenario ($Can130.26) and lowest for the ‘symptomatic treatment/30% chance of adverse effects’ scenario ($Can99.16). Bootstrap analyses indicated none of our potential determinants (e.g. age, sex) were associated with participants’ M WTP. Conclusions: The general public is willing to pay higher income taxes to fund unrestricted access to AD (especially disease-modifying) medications. Consequently, the public should favour placing new AD medications on public drug plans. As far as we are aware, no other study has elicited the general public’s willingness to pay for AD medications. Copyright Springer International Publishing AG 2012

Suggested Citation

  • Mark Oremus & Jean-Eric Tarride & Parminder Raina & Lehana Thabane & Gary Foster & Charlie Goldsmith & Natasha Clayton, 2012. "The General Public’s Willingness to Pay for Tax Increases to Support Unrestricted Access to an Alzheimer’s Disease Medication," PharmacoEconomics, Springer, vol. 30(11), pages 1085-1095, November.
    • Handle: RePEc:spr:pharme:v:30:y:2012:i:11:p:1085-1095
    DOI: 10.2165/11594180-000000000-00000
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.2165/11594180-000000000-00000
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.2165/11594180-000000000-00000?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Markus Koenig & Peter Zweifel, 2004. "Willingness-to-pay Against Dementia: Effects of Altruism Between Patients and Their Spouse Caregivers," SOI - Working Papers 0411, Socioeconomic Institute - University of Zurich.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Stefan Boes, 2013. "Nonparametric analysis of treatment effects in ordered response models," Empirical Economics, Springer, vol. 44(1), pages 81-109, February.
    2. Li-Wei Chao & José A. Pagán & Beth J. Soldo, 2008. "End-of-Life Medical Treatment Choices: Do Survival Chances and Out-of-Pocket Costs Matter?," Medical Decision Making, , vol. 28(4), pages 511-523, July.
    3. Mark Oremus & Jean-Eric Tarride & Eleanor Pullenayegum & Natasha Clayton & Parminder Raina, 2013. "Patients’ Willingness-to-Pay for an Alzheimer’s Disease Medication in Canada," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 6(3), pages 161-168, September.
    4. Halbheer, Daniel & Fehr, Ernst & Goette, Lorenz & Schmutzler, Armin, 2009. "Self-reinforcing market dominance," Games and Economic Behavior, Elsevier, vol. 67(2), pages 481-502, November.
    5. Helga Fehr-Duda & Adrian Bruhin & Thomas Epper & Renate Schubert, 2010. "Rationality on the rise: Why relative risk aversion increases with stake size," Journal of Risk and Uncertainty, Springer, vol. 40(2), pages 147-180, April.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:30:y:2012:i:11:p:1085-1095. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.